Cancer Immunotherapy Using RNA Aptamers for Cell-Selective Delivery or Intracellular Target Inhibition

• Expanding therapeutic horizons of aptamers beyond conventional targets on cell surface
• Leveraging innovative oligonucleotide chemistries to enable novel cancer treatment strategies
• Advancing conjugation technologies to enhance delivery and address complex myeloid cell biology

Speaker to be announced